Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:01:42.684Z.
Calculation as of: 2026-10-06T18:01:42.684Z.
Quote observation: 2026-10-06T18:00:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7e5dd7cae71be814523bfc9444594aa14e5919ebae0d9bfc7936539f469f7652
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$10.59M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.56M
Free Cash Flow Yield
N/A
TTM Avg
28.10%
3Y Avg
28.10%
5Y Avg
28.10%
Market Cap
$11.12M
Free Cash Flow Yield
N/A
TTM Avg
42.18%
3Y Avg
42.18%
5Y Avg
42.18%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerenome, Inc. (CNSY) | $10.89M | N/A | N/A | N/A | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.83M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $11.09M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.05M | N/A | N/A | N/A | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.59M | N/A | N/A | N/A | N/A |
| Pluri Inc. (PLUR)vs › | $10.59M | N/A | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.56M | N/A | 28.10% | 28.10% | 28.10% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | N/A | 42.18% | 42.18% | 42.18% |
| Lifeward Ltd. (LFWD)vs › | $10.52M | N/A | N/A | N/A | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.51M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
